Citation

MATTHEW O, NDOMB T, ONAKEWHOR J, MATAWAL B, OSAGIE E, et al. (2019) Multi-Center Study on the Prevalence of Human Immunodeficiency Virus/Herpes Simplex Virus Type-2 Co-Infection among Pregnant Women in Nigeria. Int J Virol AIDS 6:052. doi.org/10.23937/2469-567X/1510052

Copyright

© 2019 MATTHEW O, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

ORIGINAL ARTICLE | OPEN ACCESS DOI: 10.23937/2469-567X/1510052

Multi-Center Study on the Prevalence of Human Immunodeficiency Virus/Herpes Simplex Virus Type-2 Co-Infection among Pregnant Women in Nigeria

Olayemi MATTHEW1,2*, Teclaire NDOMB1,3, Joseph ONAKEWHOR4, Bitrus MATAWAL5, Esosa OSAGIE1,4, Alashle ABIMIKU1,3,6 and Man CHARURAT6

1Institute of Human Virology Nigeria, Nigeria

2California Miramar University, USA

3Plateau Laboratory Virology Research Center, Nigeria

4University of Benin Teaching Hospital, Nigeria

5Plateau State Specialist Hospital, Nigeria

6Institute of Human Virology, University of Maryland School of Medicine, USA

Abstract

Objectives

Substantial proportions of new HIV infections in sub-Saharan Africa are associated with herpes simplex virus type 2 (HSV-2) infection hence the magnitude of infection in the population suggests the expected course of HIV epidemic. We determined prevalence of genital herpes as a result of HSV-2 and its associated factors among pregnant women in Nigeria.

Methods

A total of 2,362 sera of pregnant women aged 18-49 years attending two different antenatal clinics in two communities in Nigeria were analysed using ELISA specific for IgG antibodies to HSV-2 (Kalon Biological Ltd, U.K). HIV antibodies were screened using sequential algorithm of rapid HIV tests.

Results

Prevalence of genital herpes was 38.8% (95% CI: 36.8-40.7%). HSV-2 was associated with first time pregnancy, high maternal age and age of sex partner in this study. 264 women (11.2%) had current symptomatic genital ulceration. Odds of HSV-2 sero-positivity was 6 times higher in HIV-sero-positive than sero-negative women (76.3% vs. 34.9%, p < 0.001). This remained significant after controlling for age, education, marital status and religion. Among HIV-sero-positive women, low CD4 and current genital ulcerative disease (GUD) were associated with higher HSV-2 prevalence.

Conclusion

HSV-2 was highly prevalent; few women had prior or current GUD. Treatment of HSV-2 in populations like pregnant women would be among approaches towards preventing and managing HIV infections.